A phase III randomized trial of high-dose CEOP + filgrastim...

American Journal of Hematology 2014 / 05 Vol. 89; Iss. 5

A phase III randomized trial of high-dose CEOP + filgrastim versus standard-dose CEOP in patients with non-Hodgkin lymphoma: 10-year follow-up data: Australasian Leukaemia and Lymphoma Group (ALLG) NHL07 trial

Hertzberg, Mark, Matthews, Jane Palfrey, Stone, Janey Malka, Dubosq, Ming-Celine, Grigg, Andrew, Ellis, David, Benson, Warwick, Browett, Peter, Horvath, Noemi, Januszewicz, Henry, Abdi, Ehtesham, Gree
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
89
Language:
english
Journal:
American Journal of Hematology
DOI:
10.1002/ajh.23684
Date:
May, 2014
File:
PDF, 542 KB
english, 2014
Conversion to is in progress
Conversion to is failed